Skip to main content
Signal8

Dambkowski Carl

SEC insider (Form 3/4/5 filer). CIK 0001983476. Chief Medical Officer at Apogee Therapeutics, Inc. (APGE) and 1 other issuer. 82 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in SAN FRANCISCO, CA.

Companies Dambkowski Carl has filed insider reports for

  • Apogee Therapeutics, Inc. (APGE): Officer, Chief Medical Officer
  • Oruka Therapeutics, Inc. (ORKA): Director
Dambkowski Carl profile photo

Dambkowski Carl

CIK: 0001983476

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)57 (69.5%)

Position reduction

Option Exercises (M)17 (20.7%)

Derivative conversions

Awards (A)4 (4.9%)

Compensation grants

Other (G, F, J, C, D, …)4 (4.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Apogee Therapeutics, Inc. logo
APGE

Apogee Therapeutics, Inc.

Officer
Oruka Therapeutics, Inc. logo
ORKA

Oruka Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (82 total)

  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Sep 3, 2026
    Disposition
    Direct
    167.1K shares-
  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Sep 2, 2026
    Disposition
    Direct
    1.4K shares at avg. $135.06$186K
  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Aug 5, 2026
    Exercise
    Direct
    4.1K shares at avg. $22.86$94K
  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Aug 5, 2026
    Sale
    Direct
    5.5K shares at avg. $134.17$738K
  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Jul 14, 2026
    Gift
    Direct
    8K shares-
  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Jul 1, 2026
    Exercise
    Direct
    4.1K shares at avg. $22.86$94K
  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Jul 1, 2026
    Sale
    Direct
    5.5K shares at avg. $132.74$730K
  • Apogee Therapeutics, Inc. logo
    APGE

    Apogee Therapeutics, Inc.

    Jun 22, 2026
    Sale
    Direct
    26.4K shares at avg. $132.60$3.5M
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Jun 12, 2026
    Sale
    Direct
    12.6K shares at avg. $70.11$882K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Jun 11, 2026
    Sale
    Direct
    22.4K shares at avg. $70.13$1.6M

1-10 of 82

…